Search

News & Events

Jake's diabetes journey Age when diagnosed; two years-old, almost three.

News & Events

JRDF One Walk

Patients, families and our centre staff members took part in JDRF's One Walk last October to raise funds for type 1 diabetes research.

News & Events

For all of our budding young actors…

We are looking to create exciting new online resources for our families to utilise, which will include how-to videos, as well as patient perspective interviews.

News & Events

Interested in insulin pump therapy but not too sure where to start?

Here's a brief guide on how to apply for insulin pump therapy.

News & Events

Diabetes Australia app

Diabetes Australia have released an app to make living with or caring for someone with diabetes a little easier.

Privacy Policy

Privacy Policy // <![CDATA[ (function (w,d) {var loader = function () {var s = d.createElement("script"), tag = d.getElementsByTagName("script")[0]; s.src = "https://cdn.iubenda.com/iubenda.js"; tag.parentNode.insertBefore(s,tag);}; if(

Be involved

Find out how to participate in our research and community groups.

Research

Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring System

Continuous glucose monitoring systems are used in therapeutic decisions for diabetes management, however, the impact of body composition on CGM accuracy is not known. Body composition variables were collected in an observational study designed to determine the accuracy of an investigational Medtronic Guardian™ sensor 3.

Research

Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry

To compare HbA1c and clinical outcomes in adolescents and young adults with type 1 diabetes, with or without celiac disease.

Research

"i Think i Could Have Used It Better": Experiences of Youth with High HbA1c Commencing Advanced Hybrid Closed-Loop Therapy in a Clinical Trial Setting - A Qualitative Research

Advanced hybrid closed-loop (AHCL) therapy improves glycemia. However, it is not known if there is an improvement in overall outcomes with AHCL for youth with type 1 diabetes (T1D) at high risk of diabetes-related complications. The study aimed to capture the experiences of youth with suboptimal glycemic control when commencing AHCL therapy in a clinical trial setting.